Xenex Disinfection Services, Inc.

Xenex is the leading manufacturer and developer of UV light disinfection robots, which play a critical role in helping hospitals to minimize their Hospital Acquired Infections (HAIs).

Xenex’s pulsed Xenon UV light approach destroys more pathogens and in less time than their competitors, while smoothly integrating into hospital cleaning operations in an easy-to-operate manner. Equally as important as its technology, Xenex has built a best-in-class commercial organization and the company’s focus on superior customer support has translated into outstanding retention and deep integration within its hospitals.The benefits to the hospitals in which these robots are utilized include improved profitability through higher reimbursement, enhanced patient health and satisfaction, decreased cost of care, and a payback period of four to nine months from the initial procurement. Xenex curently has 800+ robots in service among clients who include the Mayo Clinic, MD Anderson Center, and Stanford University Hospital and Clinics, among 320+ other well-known healthcare facilities.

Transaction Summary

  • In February 2017, EW invested $25M in a growth equity financing to accelerate the commercialization of Xenex's market-leading UV disinfection technology

Related News

“We are thrilled to partner with EW as the number one healthcare investment firm in the world, with huge successes like Abiomed, Lifecell, and many others. With their understanding of the medical device space and how companies should operate, EW has added value from ‘Day 1’. We were very impressed with the careful diligence conducted by the EW team, and we look forward to a great future together!”

Morris Miller

CEO, Xenex